The R&D pipeline reflects our long-term commitment to driving change to defeat obesity, haemophilia, growth disorders and other serious chronic diseases
Facts and figures specific to our Research & Development organisation
We have teamed up with the International Red Cross and Red Crescent Movement to solve the challenge of delivering care to vulnerable populations displaced by conflict.
Click through to find the answers to some of our more frequently asked questions on sustainability and responsible business practices.
We are driven by science, innovation and research and strive to share our knowledge with the global community.
Patients with diabetes often have comorbid conditions and overlapping CVD risk factors that drive CVD and other complications
T2D and the common comorbid conditions of hypertension and
dyslipidaemia all carry independent risk for ASCVD.1
CV=cardiovascular; CVD=cardiovascular disease; T2D=type 2 diabetes;
CHD=coronary heart disease; CAD=coronary artery disease;
PAD=peripheral artery disease; ASCVD=atherosclerotic cardiovascular disease.
HQMMA/NNG/0217/0035, March 2017